<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02016612</url>
  </required_header>
  <id_info>
    <org_study_id>007</org_study_id>
    <nct_id>NCT02016612</nct_id>
  </id_info>
  <brief_title>Seri Surgical Scaffold Support of the Lower Pole of the Breast</brief_title>
  <acronym>SeriSupport</acronym>
  <official_title>Seri Surgical Scaffold (TM) Support of the Lower Pole of the Breasts in Augmentation Mastopexy or Breast Reduction Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bengtson Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Allergan Medical</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Bengtson Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Will the use of an FDA approved highly purified silk scaffold; Seri Surgical Scaffold help
      shape and hold the breast up on the chest preventing re-stretching and bottoming out of the
      breast in breast reduction or augmentation-mastopexy patients? The amount of stretch will be
      measured manually as well as percent of breast tissue measured with the Canfield Vectra 3-D
      Imaging system reporting the amount of breast tissue above and below the nipple level.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients having augmentation mastopexy or breast reduction will be informed about Seri
      Scaffold and allowed to have Seri support included in their surgery or not. If the choose the
      scaffold will be placed under the skin in the lower pole of the breast as an internal hammock
      to help take weight off of the breast and potentially help prevent future stretch of the
      lower pole.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">November 30, 2016</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nipple to Fold Measurement on Stretch</measure>
    <time_frame>1 year post op</time_frame>
    <description>The Nipple to fold will be measured manually over time to 1 year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent Breast Tissue Above Nipple</measure>
    <time_frame>1 year post op</time_frame>
    <description>The percentage of breast tissue above and below the horizontal plane of the nipple over time</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Recurrent Ptosis of the Breast</condition>
  <arm_group>
    <arm_group_label>Reduction, Mastopexy No Implant, No Seri</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergoing reduction or mastopexy but no implant is used and no Seri Surgical Scaffold support is used</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mastopexy, Implant no Seri Scaffold</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mastopexy with implant, No Seri Surgical Scaffold support is used</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Breast Reduction with Seri Support</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergoing breast reduction with the use of Seri Surgical scaffold support</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Augmentation Mastopexy, Implant and Seri</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Augmentation Mastopexy patients where Seri Surgical scaffold is used</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Seri Surgical Scaffold</intervention_name>
    <description>An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
    <arm_group_label>Reduction, Mastopexy No Implant, No Seri</arm_group_label>
    <arm_group_label>Mastopexy, Implant no Seri Scaffold</arm_group_label>
    <arm_group_label>Breast Reduction with Seri Support</arm_group_label>
    <arm_group_label>Augmentation Mastopexy, Implant and Seri</arm_group_label>
    <other_name>Seri</other_name>
    <other_name>Seri Scaffold</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age =&gt;18 years

          -  requesting procedure

          -  No active cancer or infection

        Exclusion Criteria:

          -  Known allergy to silk

          -  Pregnant or lactating
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bradley P Bengtson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bengtson Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bengtson Center for Aesthetics and Plastic Surgery</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Aesthetics and Plastic Surgery</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 16, 2013</study_first_submitted>
  <study_first_submitted_qc>December 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 20, 2013</study_first_posted>
  <results_first_submitted>November 15, 2016</results_first_submitted>
  <results_first_submitted_qc>January 17, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">February 13, 2018</results_first_posted>
  <last_update_submitted>January 17, 2018</last_update_submitted>
  <last_update_submitted_qc>January 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bengtson Center</investigator_affiliation>
    <investigator_full_name>Bradley Bengtson, M.D.</investigator_full_name>
    <investigator_title>Bradley P Bengtson, MD FACS</investigator_title>
  </responsible_party>
  <keyword>Recurrent</keyword>
  <keyword>Ptosis</keyword>
  <keyword>Reduction</keyword>
  <keyword>Mammoplasty</keyword>
  <keyword>Mastopexy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Reduction, Mastopexy No Implant, No Seri</title>
          <description>Patients undergoing reduction or mastopexy but no implant is used and no Seri support
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
        </group>
        <group group_id="P2">
          <title>Mastopexy, Implant no Seri Scaffold</title>
          <description>Mastopexy with implant, No Seri support is used
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
        </group>
        <group group_id="P3">
          <title>Breast Reduction With Seri Support</title>
          <description>Patients undergoing breast reduction with the use of Seri support
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
        </group>
        <group group_id="P4">
          <title>Augmentation Mastopexy, Implant and Seri</title>
          <description>Augmentation Mastopexy patients where Seri Scaffold is placed
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="26"/>
                <participants group_id="P4" count="61"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="26"/>
                <participants group_id="P4" count="61"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Reduction, Mastopexy No Implant, No Seri</title>
          <description>Patients undergoing reduction or mastopexy but no implant is used and no Seri support
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
        </group>
        <group group_id="B2">
          <title>Mastopexy, Implant no Seri Scaffold</title>
          <description>Mastopexy with implant, No Seri support is used
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
        </group>
        <group group_id="B3">
          <title>Breast Reduction With Seri Support</title>
          <description>Patients undergoing breast reduction with the use of Seri support
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
        </group>
        <group group_id="B4">
          <title>Augmentation Mastopexy, Implant and Seri</title>
          <description>Augmentation Mastopexy patients where Seri Scaffold is placed
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="26"/>
            <count group_id="B4" value="61"/>
            <count group_id="B5" value="137"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="61"/>
                    <measurement group_id="B5" value="137"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47" lower_limit="20" upper_limit="63"/>
                    <measurement group_id="B2" value="38" lower_limit="20" upper_limit="56"/>
                    <measurement group_id="B3" value="48" lower_limit="39" upper_limit="65"/>
                    <measurement group_id="B4" value="37" lower_limit="26" upper_limit="65"/>
                    <measurement group_id="B5" value="42" lower_limit="20" upper_limit="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="61"/>
                    <measurement group_id="B5" value="137"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="61"/>
                    <measurement group_id="B5" value="128"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="61"/>
                    <measurement group_id="B5" value="137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Nipple to Fold Measurement on Stretch</title>
        <description>The Nipple to fold will be measured manually over time to 1 year</description>
        <time_frame>1 year post op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Reduction, Mastopexy No Implant, No Seri</title>
            <description>Patients undergoing reduction or mastopexy but no implant is used and no Seri support
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
          </group>
          <group group_id="O2">
            <title>Mastopexy, Implant no Seri Scaffold</title>
            <description>Mastopexy with implant, No Seri support is used
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
          </group>
          <group group_id="O3">
            <title>Breast Reduction With Seri Support</title>
            <description>Patients undergoing breast reduction with the use of Seri support
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
          </group>
          <group group_id="O4">
            <title>Augmentation Mastopexy, Implant and Seri</title>
            <description>Augmentation Mastopexy patients where Seri Scaffold is placed
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
          </group>
        </group_list>
        <measure>
          <title>Nipple to Fold Measurement on Stretch</title>
          <description>The Nipple to fold will be measured manually over time to 1 year</description>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="26"/>
                <count group_id="O4" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" lower_limit="1.2" upper_limit="4.2"/>
                    <measurement group_id="O2" value="2.5" lower_limit="1.2" upper_limit="4.1"/>
                    <measurement group_id="O3" value="1.4" lower_limit="0.5" upper_limit="2.6"/>
                    <measurement group_id="O4" value="1.4" lower_limit="0.7" upper_limit="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Breast Tissue Above Nipple</title>
        <description>The percentage of breast tissue above and below the horizontal plane of the nipple over time</description>
        <time_frame>1 year post op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Reduction, Mastopexy No Implant, No Seri</title>
            <description>Patients undergoing reduction or mastopexy but no implant is used and no Seri support
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
          </group>
          <group group_id="O2">
            <title>Mastopexy, Implant no Seri Scaffold</title>
            <description>Mastopexy with implant, No Seri support is used
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
          </group>
          <group group_id="O3">
            <title>Breast Reduction With Seri Support</title>
            <description>Patients undergoing breast reduction with the use of Seri support
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
          </group>
          <group group_id="O4">
            <title>Augmentation Mastopexy, Implant and Seri</title>
            <description>Augmentation Mastopexy patients where Seri Scaffold is placed
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Breast Tissue Above Nipple</title>
          <description>The percentage of breast tissue above and below the horizontal plane of the nipple over time</description>
          <units>percentage of volume</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="26"/>
                <count group_id="O4" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35" lower_limit="0.0" upper_limit="100"/>
                    <measurement group_id="O2" value="30" lower_limit="0" upper_limit="100"/>
                    <measurement group_id="O3" value="15" lower_limit="0" upper_limit="100"/>
                    <measurement group_id="O4" value="18" lower_limit="0" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Reduction, Mastopexy No Implant, No Seri</title>
          <description>Patients undergoing reduction or mastopexy but no implant is used and no Seri support
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
        </group>
        <group group_id="E2">
          <title>Mastopexy, Implant no Seri Scaffold</title>
          <description>Mastopexy with implant, No Seri support is used
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
        </group>
        <group group_id="E3">
          <title>Breast Reduction With Seri Support</title>
          <description>Patients undergoing breast reduction with the use of Seri support
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
        </group>
        <group group_id="E4">
          <title>Augmentation Mastopexy, Implant and Seri</title>
          <description>Augmentation Mastopexy patients where Seri Scaffold is placed
Seri Surgical Scaffold: An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>seroma</sub_title>
                <description>seroma and partial Seri removal</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>dehiscence</sub_title>
                <description>skin dehiscence</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>skin dehiscence</sub_title>
                <description>skin dehiscence</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Superficial infection limited to the skin</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Bradley Bengtson</name_or_title>
      <organization>Bengtson Center</organization>
      <phone>616 588 8880</phone>
      <email>drb@bengtsoncenter.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

